# A Study to Assess Drug Levels, Tolerability and Absolute Biological Availability of Single-dose of BMS-986446 in Healthy Participants

> **NCT06955741** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 46 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** BMS-986446 IV
- **DRUG:** BMS-986446 SC
- **DRUG:** Acetaminophen
- **DRUG:** Loratadine

## Key facts

- **NCT ID:** NCT06955741
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-05-05
- **Primary completion:** 2025-09-11
- **Final completion:** 2025-09-11
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2025-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06955741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06955741, "A Study to Assess Drug Levels, Tolerability and Absolute Biological Availability of Single-dose of BMS-986446 in Healthy Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06955741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*